20
Participants
Start Date
October 31, 2014
Primary Completion Date
January 31, 2015
Study Completion Date
January 31, 2015
D3 Creatine
One dose of D3 Creatine (60mg capsule) given orally on Day 1
Creatine
Participants will consume an individual dosed level of creatine, based on their estimated muscle mass in doses of 0.03, 0.035, 0.04, 0.045 g.kg.Lean mass/day, increasing on a weekly basis. Final dose of 0.05 g.kg.Lean mass/day is then maintained throughout the study.
GSK Investigational Site, Brentford
Lead Sponsor
GlaxoSmithKline
INDUSTRY